T. Rowe Price Associates’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
|
|||||
|
2025
Q1 | $3.49M | Sell |
|
|||||
|
2024
Q4 | $4.42M | Sell |
|
|||||
|
2024
Q3 | $10.1M | Sell |
|
|||||
|
2024
Q2 | $11.4M | Buy |
|
|||||
|
2024
Q1 | $15M | Buy |
|
|||||
|
2023
Q4 | $12.9M | Sell |
|
|||||
|
2023
Q3 | $9.83M | Sell |
|
|||||
|
2023
Q2 | $26M | Buy |
|
|||||
|
2023
Q1 | $9.36M | Buy |
|
|||||
|
2022
Q4 | $12.8M | Sell |
|
|||||
|
2022
Q3 | $38.9M | Sell |
|
|||||
|
2022
Q2 | $34.7M | Sell |
|
|||||
|
2022
Q1 | $27.7M | Buy |
|
|||||
|
2021
Q4 | $39.8M | Buy |
|
|||||
|
2021
Q3 | $54.2M | Buy |
|
|||||
|
2021
Q2 | $40.6M | Buy |
|